The SH-SY5Y cell line: a valuable tool for Parkinson's disease drug discovery.

Parkinson’s disease SH-SY5Y cell line genetic relationship in vitro model molecular environment nanotechnology

Journal

Expert opinion on drug discovery
ISSN: 1746-045X
Titre abrégé: Expert Opin Drug Discov
Pays: England
ID NLM: 101295755

Informations de publication

Date de publication:
19 Dec 2023
Historique:
medline: 19 12 2023
pubmed: 19 12 2023
entrez: 19 12 2023
Statut: aheadofprint

Résumé

Owing to limited efficient treatment strategies for highly prevalent and distressing Parkinson's disease (PD), an impending need emerged for deciphering new modes and mechanisms for effective management. SH-SY5Y-based Herein, the authors review the SH-SY5Y cell line and its value to PD research. The authors also provide the reader with their expert perspectives on how these developments can lead to the development of new impactful therapeutics. Encouraged by recent research on SH-SY5Y cell lines, it was envisaged that this

Identifiants

pubmed: 38112196
doi: 10.1080/17460441.2023.2293158
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-14

Auteurs

Manisha Pandey (M)

Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh, India.

Varnita Karmakar (V)

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India.

Ankit Majie (A)

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India.

Monika Dwivedi (M)

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India.

Shadab Md (S)

Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

Bapi Gorain (B)

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India.

Classifications MeSH